Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
6
|
Resverlogix Corp.
|
Nov 30, 2021 02:46AM
|
Re: Not adding up!
|
3
|
Zenith Epigenetics
|
Nov 15, 2021 09:09PM
|
Re: Nonprofit Think Tank
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 10:20PM
|
Re: No word on...
|
2
|
Resverlogix Corp.
|
Jul 14, 2021 01:39AM
|
Re: No word on...
|
1
|
Resverlogix Corp.
|
Jul 15, 2021 12:24PM
|
Re: No word on...
|
7
|
Resverlogix Corp.
|
Jul 12, 2021 05:30PM
|
Re: No change in Ottawa.
|
2
|
Resverlogix Corp.
|
Sep 22, 2021 12:50PM
|
Re: Nice to read one employee's assessment about EVERSANA.
|
4
|
Resverlogix Corp.
|
Jul 14, 2021 04:52PM
|
Re: News report on last NR
|
4
|
Resverlogix Corp.
|
Mar 05, 2021 11:44PM
|
Re: News report on last NR
|
5
|
Resverlogix Corp.
|
Mar 05, 2021 09:33PM
|
Re: News release
|
4
|
Resverlogix Corp.
|
Aug 28, 2020 09:48PM
|
Re: New treatment for COVID-19 discovered in human skin cells.
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 12:12PM
|
Re: New treatment for COVID-19 discovered in human skin cells.
|
5
|
Resverlogix Corp.
|
Mar 12, 2022 01:33PM
|
Re: New RVX Video - from Fontier Merchant Capital Group
|
5
|
Resverlogix Corp.
|
Feb 26, 2022 05:59PM
|
Re: New RVX Tweet
|
6
|
Resverlogix Corp.
|
Aug 01, 2020 09:09PM
|
Re: New Pfizer Antiviral Drug
|
2
|
Resverlogix Corp.
|
Nov 05, 2021 09:26AM
|
Re: New Pfizer Antiviral Drug
|
4
|
Resverlogix Corp.
|
Nov 05, 2021 08:08PM
|
Re: New name.
|
3
|
Resverlogix Corp.
|
May 10, 2022 10:47PM
|
Re: New exempt distribution
|
2
|
Resverlogix Corp.
|
May 06, 2021 03:21PM
|
Re: New Apabetalone Fabry Disease Publication
|
9
|
Resverlogix Corp.
|
Apr 28, 2022 12:53PM
|